Modified P200TE Data Collection | Clinical Trial

Key information

Conditions

Retina Disease

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Bennett & Bloom Eye Centers

Louisville, Kentucky, 40222, United States

Location status: Recruiting

Location contact

Megan Kingdon

CONTACT

[email protected]

(502) 895-0040

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or female participants 22 years of age or older who have full legal capacity to volunteer on the date the informed consent is signed

Participants who can follow the instructions by the clinical staff at the clinical site

Participants who agree to participate in the study

Participants with posterior segment eye disease. Example of pathologies may include but are not limited to Age-related macular degeneration, glaucoma, diabetic retinopathy, posterior uveitis, central serous chorioretinopathy, vein occlusion, epiretinal membrane and others as confirmed by the investigator.

Exclusion criteria

Participants unable to tolerate ophthalmic imaging.

Participants with ocular media not sufficiently clear to obtain acceptable images.

Unable to obtain acceptable image quality on participant.

Treatment and study plan

imaging device

Device

images captured on a modified P200TE

Primary outcomes

Number of images

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Optos, PLC

Industry

Registry information

Important dates

Study start: 2026
Primary completion: 2026
Study completion: 2026
First posted: Sep 1, 2026
Registry last updated: Sep 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting